Dr. Adam Klein is a neuropsychopharmacologist who specializes in understanding the neural and behavioral effects of psychedelic drugs. He has over a dozen publications on the neurobiology of psychedelics and other drugs and has presented his work at top conferences in both neuroscience and pharmacology. Dr. Klein currently works as a Senior Scientist at Gilgamesh Pharmaceuticals, a small biotech that is developing psychedelic, and psychedelic-inspired drugs to be the next generation of treatments for mental health. Additionally, “Dr. Adam” volunteers with RGX Medical to provide first-aid and a sanctuary space at music festivals. He also works closely with DanceSafe, a non-profit peer-to-peer harm reduction organization that provides drug education and drug checking services at music festivals.

Get Tickets Here